Market Access Reuters Europe 2025: Using value propositions to improve acc... In a Reuters Pharma Europe 2025 fireside chat, NICE Advice Director Brad Grove spoke with Novartis's Matic Meglic about novel pharma payment models.
Market Access Reuters Europe 2025: Trade-offs in European launch sequencin... At Reuters, industry stakeholders discussed how, especially in light of the current tariff crisis, Europe must operate as a unit when pricing drugs.
Market Access Reuters Europe 2025: Collaboration key for innovation, BI he... At Reuters Pharma Europe, Francesco Di Marco of Boehringer Ingelheim focused on the importance of innovating together.
Digital Reuters Pharma Europe 2025: Access, AI dominate keynote talk... The opening sessions of Reuters Pharma Europe 2025 focused on global access challenges and the transformative potential of AI.
News UK's long-term R&D investment policy welcomed The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.